DNA Methylation of PI3K/AKT Pathway-Related Genes Predicts Outcome in Patients with Pancreatic Cancer: A Comprehensive Bioinformatics-Based Study

An overview of genetic mutations and epigenetic signatures in the course of pancreatic cancer progression

(2021) Aamir Ali Khan et al.   CANCER AND METASTASIS REVIEWS

Abnormal promoter DNA hypermethylation of the integrin, nidogen, and dystroglycan genes in breast cancer

(2021) Vladimir V. Strelnikov et al.   Scientific Reports

Cancer statistics, 2020

(2020) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Identification of DNA methylation‑driven genes by integrative analysis of DNA methylation and transcriptome data in pancreatic adenocarcinoma

(2020) Wei Zhang et al.   Experimental and Therapeutic Medicine

Molecular profiling of stroma highlights stratifin as a novel biomarker of poor prognosis in pancreatic ductal adenocarcinoma

(2020) Fabien Robin et al.   BRITISH JOURNAL OF CANCER

Differential methylation landscape of pancreatic ductal adenocarcinoma and its precancerous lesions

(2020) A. Bararia et al.   Hepatobiliary & Pancreatic Diseases International

Visualizing and interpreting cancer genomics data via the Xena platform

(2020) Mary J. Goldman et al.   NATURE BIOTECHNOLOGY

Pancreatic cancer

(2020) Jonathan D Mizrahi et al.   LANCET

Identifying potential DNA methylation markers in early-stage colorectal Cancer

(2020) Xiaoyu Zhang et al.   GENOMICS

Early Diagnosis of Pancreatic Cancer: The Key for Survival

(2020) Gina Gheorghe et al.   Diagnostics

DNA hypomethylation-related overexpression of SFN, GORASP2 and ZYG11A is a novel prognostic biomarker for early stage lung adenocarcinoma

(2019) Ryan Edbert Husni et al.   Oncotarget

Molecular subtypes of pancreatic cancer

(2019) Eric A. Collisson et al.   Nature Reviews Gastroenterology & Hepatology

Integrin Signaling in Cancer: Mechanotransduction, Stemness, Epithelial Plasticity, and Therapeutic Resistance

(2019) Jonathan Cooper et al.   CANCER CELL

The relation between PI3K/AKT signalling pathway and cancer

(2019) Saeed Noorolyai et al.   GENE

TET1-mediated DNA hydroxymethylation activates inhibitors of the Wnt/β-catenin signaling pathway to suppress EMT in pancreatic tumor cells

(2019) Jian Wu et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Deciphering DNA methylation signatures of pancreatic cancer and pancreatitis

(2019) Francesco Natale et al.   Clinical Epigenetics

DNA methylation biomarkers discovered in silico detect cancer in liquid biopsies from non-small cell lung cancer patients

(2019) Lukas Vrba et al.   Epigenetics

DNA Methylation Cancer Biomarkers: Translation to the Clinic

(2019) Warwick J. Locke et al.   Frontiers in Genetics

Role of stratifin (14-3-3 sigma) in adenocarcinoma of gallbladder: A novel prognostic biomarker

(2019) Vorapan Sirivatanauksorn et al.   SURGICAL ONCOLOGY-OXFORD

Cell-Free DNA Methylation: The New Frontiers of Pancreatic Cancer Biomarkers’ Discovery

(2019) Mariarita Brancaccio et al.   Genes

Distinct epigenetic landscapes underlie the pathobiology of pancreatic cancer subtypes

(2018) Gwen Lomberk et al.   Nature Communications

Hypermethylation of gene body CpG islands predicts high dosage of functional oncogenes in liver cancer

(2018) Maria Arechederra et al.   Nature Communications

Circulating Tumor Cells and Cell-Free DNA in Pancreatic Ductal Adenocarcinoma

(2018) Tamara M.H. Gall et al.   AMERICAN JOURNAL OF PATHOLOGY

Combating pancreatic cancer with PI3K pathway inhibitors in the era of personalised medicine

(2018) James RW Conway et al.   GUT

The TERT hypermethylated oncologic region predicts recurrence and survival in pancreatic cancer

(2017) Inês Faleiro et al.   Future Oncology

Altered hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways

(2017) Sanchari Bhattacharyya et al.   GENOME RESEARCH

Early detection of pancreatic cancer: Where are we now and where are we going?

(2017) Bin Zhou et al.   INTERNATIONAL JOURNAL OF CANCER

Acinar cell plasticity and development of pancreatic ductal adenocarcinoma

(2017) Peter Storz   Nature Reviews Gastroenterology & Hepatology

The Pancreatic Expression Database: 2018 update

(2017) Jacek Marzec et al.   NUCLEIC ACIDS RESEARCH

Epigenetic alterations as biomarkers in pancreatic ductal adenocarcinoma

(2017) Pascal Syren et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts

(2017) Rémy Nicolle et al.   Cell Reports

Diagnostic Accuracy of Methylated SEPT9 for Blood-based Colorectal Cancer Detection: A Systematic Review and Meta-Analysis

(2017) Jiayun Nian et al.   Clinical and Translational Gastroenterology

Molecular Biomarkers of Pancreatic Intraepithelial Neoplasia and Their Implications in Early Diagnosis and Therapeutic Intervention of Pancreatic Cancer

(2016) Junli Guo et al.   International Journal of Biological Sciences

Genomic analyses identify molecular subtypes of pancreatic cancer

(2016) Peter Bailey et al.   NATURE

Accumulated promoter methylation as a potential biomarker for esophageal cancer

(2016) Xianzhen Peng et al.   Oncotarget

Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2015) M. Ducreux et al.   ANNALS OF ONCOLOGY

Implication of epigenetics in pancreas development and disease

(2015) Evans Quilichini et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

p85α is a microRNA target and affects chemosensitivity in pancreatic cancer

(2015) Paul A. Toste et al.   JOURNAL OF SURGICAL RESEARCH

Whole genomes redefine the mutational landscape of pancreatic cancer

(2015) Nicola Waddell et al.   NATURE

A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition

(2015) Wenting Xu et al.   Cell Adhesion & Migration

Pancreatic Cancer Patient Survival Correlates with DNA Methylation of Pancreas Development Genes

(2015) Michael J. Thompson et al.   PLoS One

Oncogenic KRAS signalling in pancreatic cancer

(2014) S Eser et al.   BRITISH JOURNAL OF CANCER

Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling

(2014) Katia Nones et al.   INTERNATIONAL JOURNAL OF CANCER

Molecular pathology of pancreatic cancer

(2014) Yuriko Saiki et al.   PATHOLOGY INTERNATIONAL

Epigenetics and pancreatic cancer: Pathophysiology and novel treatment aspects

(2014) Daniel Neureiter   WORLD JOURNAL OF GASTROENTEROLOGY

A KRAS-directed transcriptional silencing pathway that mediates the CpG island methylator phenotype

(2014) Ryan W Serra et al.   eLife

PI3K/Akt/mTOR pathway inhibitors in the therapy of pancreatic neuroendocrine tumors

(2013) Edward M. Wolin   CANCER LETTERS

Integration of Metabolomics and Transcriptomics Revealed a Fatty Acid Network Exerting Growth Inhibitory Effects in Human Pancreatic Cancer

(2013) G. Zhang et al.   CLINICAL CANCER RESEARCH

Diverse Mechanisms of AKT Pathway Activation in Human Malignancy

(2013) Mitchell Cheung et al.   CURRENT CANCER DRUG TARGETS

Modification of Enhancer Chromatin: What, How, and Why?

(2013) Eliezer Calo et al.   MOLECULAR CELL

TET enzymes, TDG and the dynamics of DNA demethylation

(2013) Rahul M. Kohli et al.   NATURE

The pancreatic expression database: recent extensions and updates

(2013) Abu Z. Dayem Ullah et al.   NUCLEIC ACIDS RESEARCH

Epigenetic biomarkers: A new perspective in laboratory diagnostics

(2012) J.L. García-Giménez et al.   CLINICA CHIMICA ACTA

Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer

(2012) Jordan M. Winter et al.   JOURNAL OF SURGICAL ONCOLOGY

DNA methylation profiling in the clinic: applications and challenges

(2012) Holger Heyn et al.   NATURE REVIEWS GENETICS

Functions of DNA methylation: islands, start sites, gene bodies and beyond

(2012) Peter A. Jones   NATURE REVIEWS GENETICS

DPEP1 Inhibits Tumor Cell Invasiveness, Enhances Chemosensitivity and Predicts Clinical Outcome in Pancreatic Ductal Adenocarcinoma

(2012) Geng Zhang et al.   PLoS One

Evaluation of α2-Integrin Expression as a Biomarker for Tumor Growth Inhibition for the Investigational Integrin Inhibitor E7820 in Preclinical and Clinical Studies

(2011) Ron J. Keizer et al.   AAPS Journal

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Neuroendocrine Pancreatic Tumors: Guidelines for Management and Update

(2011) William R. Burns et al.   CURRENT TREATMENT OPTIONS IN ONCOLOGY

Histone H3K27ac separates active from poised enhancers and predicts developmental state

(2010) M. P. Creyghton et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A Six-Gene Signature Predicts Survival of Patients with Localized Pancreatic Ductal Adenocarcinoma

(2010) Jeran K. Stratford et al.   PLOS MEDICINE

Clinical significance of Stratifin, ERα and PR promoter methylation in tumor and serum DNA in Indian breast cancer patients

(2009) Sameer Mirza et al.   CLINICAL BIOCHEMISTRY

Pancreatic cancer: molecular pathogenesis and new therapeutic targets

(2009) Han H. Wong et al.   Nature Reviews Gastroenterology & Hepatology

14-3-3  Modulates Pancreatic Cancer Cell Survival and Invasiveness

(2008) D. Neupane et al.   CLINICAL CANCER RESEARCH